脂鲤技术 TTI 深 沪
交易中 01-30 10:22:06 美东时间
11.56
0.000
0.00%
华盛通- 最 高11.68
- 今 开11.525
- 成交量 8.78万股
- 最 低 11.42
- 昨 收 11.56
- 总市值 15.49亿
- 52周最高 12.25
- 市盈率 静 14.12
- 换手率 0.07%
- 52周最低 2.0335
- 委 比 -77.78%
- 总股本 1.34亿
- 历史最高 13.43
- 量 比 0.50
- 振 幅 2.25%
- 历史最低 0.22
- 每 手 1
- 风险率 2.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 奈飞绩后遭13家大行下调目标价；齐昂银行、美国合众银行获多家机构上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从9美元升至50美元；韦德布什：维持Ardelyx, Inc."跑赢大市"评级，目标价从16美元升至19美元
01-22 15:09
This Darden Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-21 20:11
Clear Street Downgrades Tetra Technologies to Hold, Raises Price Target to $11
Clear Street analyst Tim Moore downgrades Tetra Technologies (NYSE:TTI) from Buy to Hold and raises the price target from $10 to $11.
01-21 17:24
Under the Radar: Using Growth & Momentum Together to Find the Next Market Leaders
One of the biggest mistakes investors make is treating growth and momentum as c...
01-14 00:42
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Stifel Maintains Buy on Tetra Technologies, Raises Price Target to $13
Stifel analyst Stephen Gengaro maintains Tetra Technologies (NYSE:TTI) with a Buy and raises the price target from $9 to $13.
01-13 01:58
美股大行评级 | 潜在涨幅108.88%！TeraWulf获Keefe, Bruyette & Woods上调目标价至24美元，评级升至"跑赢大市"
今日重点评级关注：Keefe, Bruyette & Woods：上调TeraWulf Inc Ordinary Shares评级至"跑赢大市"，目标价从9.5美元升至24美元；B. Riley证券：维持万达生物制药"买入"评级，目标价从11美元升至14美元
01-02 15:10
Northland Capital Markets Maintains Outperform on Tetra Technologies, Raises Price Target to $11.5
Northland Capital Markets analyst Greg Gibas maintains Tetra Technologies (NYSE:TTI) with a Outperform and raises the price target from $8.5 to $11.5.
01-01 01:28
美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
2025-12-12 10:24
CJS Securities Initiates Coverage On Tetra Technologies with Outperform Rating, Announces Price Target of $11.5
CJS Securities analyst Jonathan Tanwanteng initiates coverage on Tetra Technologies (NYSE:TTI) with a Outperform rating and announces Price Target of $11.5.
2025-12-12 03:06
